4. Apr 2017
Hotel room? Check. Flight? Check. Taxi to the airport? Check. What about getting from the airport to your hotel in the city centre? An airport transfer bus could be the best option. Chances are, if you’re an inbound or infrequent traveller, you will wonder where to search and book this last leg. Imagine if that was taken care of through your travel retailer, removing all the uncertainty and stress, just as you would book a flight.
28. Mar 2017
Magdeburg/Wittenberg, 28 March 2017 – IBG Risikokapitalfonds III (IBG), managed by bmp Beteiligungsmanagement AG (bmp), is investing several million euros in commercial storage system manufacturer TESVOLT. The young company from Wittenberg develops and produces lithium battery-storage systems for commercial customers. The IBG investments will go toward the further development of TESVOLT technology. In addition, the production lines will be expanded to be able to meet increased demand. Further resources will be used to finance national and international marketing and sales activities.
17. Mar 2017
bubbles and beyond (B&B) brand intelligent fluids® is on the ideal path to setting a new market standard for smart physical cleaning in many industrial segments. A considerable capital increase has just been carried out in order to continue expanding its leading position globally.
10. Feb 2017
1. Feb 2017
31. Jan 2017
EUCODIS Bioscience is glad to announce that it has teamed up with Tube Pharmaceuticals to bring the production of tubulysins to a commercial level. Tube Pharmaceuticals and EUCODIS now jointly produce and commercialize tubulysin A and B and other variants of this cytotoxic compound.
24. Jan 2017
IBG Beteiligungsgesellschaft Sachsen-Anhalt GmbH, a wholly-owned subsidiary of the state of Saxony-Anhalt, has launched the new venture capital fund RKF III with a volume of EUR 50 million.
9. Jan 2017
The Supervisory Board of bmp Beteiligungsmanagement AG ("bmp") has appointed Dr. Jan Alberti to the Management Board as of January 1, 2017. He now runs the company together with Oliver Borrmann and Andreas van Bon.
Dr. Jan Alberti will be dedicated to new acquisitions and business development of portfolio companies as well as to the acquisition of new fund mandates and will be responsible for marketing.
8. Dec 2016
16. Nov 2016
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), announced today the first results of a preclinical study in an AD mouse model with the pyroglutamate-3 Abeta (pGlu3-Abeta)-specific antibody mPBD-C06, comparing versions with and without a mutation eliminating complement activation which will be presented as a poster at the Society for Neuroscience (SfN) meeting on 16 November 2016 in San Diego, CA.